BIRC5 and neoplasm: In addition to its critical role in inhibiting cell death, survivin is expressed at low levels or absent in terminally differentiated healthy cells, but its expression is significantly elevated in human tumours and its overexpression is further enhanced when exposed to traditional anticancer treatments24–26.